152 related articles for article (PubMed ID: 19263516)
1. TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest.
Evangelisti C; Astolfi A; Gaboardi GC; Tazzari P; Pession A; Goto K; Martelli AM
Cell Signal; 2009 May; 21(5):801-9. PubMed ID: 19263516
[TBL] [Abstract][Full Text] [Related]
2. Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts.
Evangelisti C; Tazzari PL; Riccio M; Fiume R; Hozumi Y; Falà F; Goto K; Manzoli L; Cocco L; Martelli AM
FASEB J; 2007 Oct; 21(12):3297-307. PubMed ID: 17488950
[TBL] [Abstract][Full Text] [Related]
3. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
4. HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression.
Micheli L; D'Andrea G; Leonardi L; Tirone F
J Cell Physiol; 2017 Jul; 232(7):1696-1707. PubMed ID: 27333946
[TBL] [Abstract][Full Text] [Related]
5. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
6. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
7. Subnuclear localization and differentiation-dependent increased expression of DGK-zeta in C2C12 mouse myoblasts.
Evangelisti C; Riccio M; Faenza I; Zini N; Hozumi Y; Goto K; Cocco L; Martelli AM
J Cell Physiol; 2006 Nov; 209(2):370-8. PubMed ID: 16897754
[TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol kinase δ controls down-regulation of cyclin D1 for C2C12 myogenic differentiation.
Sakai H; Murakami C; Matsumoto KI; Urano T; Sakane F
Biochimie; 2018 Aug; 151():45-53. PubMed ID: 29859210
[TBL] [Abstract][Full Text] [Related]
9. Identification of a functional nuclear export sequence in diacylglycerol kinase-zeta.
Evangelisti C; Gaboardi GC; Billi AM; Ognibene A; Goto K; Tazzari PL; McCubrey JA; Martelli AM
Cell Cycle; 2010 Jan; 9(2):384-8. PubMed ID: 20023381
[TBL] [Abstract][Full Text] [Related]
10. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
el-Ghissassi F; Valsesia-Wittmann S; Falette N; Duriez C; Walden PD; Puisieux A
Oncogene; 2002 Oct; 21(44):6772-78. PubMed ID: 12360398
[TBL] [Abstract][Full Text] [Related]
11. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes.
Micheli L; Ceccarelli M; Farioli-Vecchioli S; Tirone F
J Cell Physiol; 2015 Dec; 230(12):2881-90. PubMed ID: 25967096
[TBL] [Abstract][Full Text] [Related]
12. Expression of B-cell translocation gene 2 protein in normal human tissues.
Melamed J; Kernizan S; Walden PD
Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
[TBL] [Abstract][Full Text] [Related]
14. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
[TBL] [Abstract][Full Text] [Related]
15. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.
Guardavaccaro D; Corrente G; Covone F; Micheli L; D'Agnano I; Starace G; Caruso M; Tirone F
Mol Cell Biol; 2000 Mar; 20(5):1797-815. PubMed ID: 10669755
[TBL] [Abstract][Full Text] [Related]
16. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
Lim YB; Park TJ; Lim IK
J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
[TBL] [Abstract][Full Text] [Related]
17. Dual control of neurogenesis by PC3 through cell cycle inhibition and induction of Math1.
Canzoniere D; Farioli-Vecchioli S; Conti F; Ciotti MT; Tata AM; Augusti-Tocco G; Mattei E; Lakshmana MK; Krizhanovsky V; Reeves SA; Giovannoni R; Castano F; Servadio A; Ben-Arie N; Tirone F
J Neurosci; 2004 Mar; 24(13):3355-69. PubMed ID: 15056715
[TBL] [Abstract][Full Text] [Related]
18. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
19. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C regulates the nuclear localization of diacylglycerol kinase-zeta.
Topham MK; Bunting M; Zimmerman GA; McIntyre TM; Blackshear PJ; Prescott SM
Nature; 1998 Aug; 394(6694):697-700. PubMed ID: 9716136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
